Patients with cardiac disease demonstrated higher expression of myocardial PD-L1 compared to controls [18], and the administration of PD-L1 was shown to attenuate myocardial injury in a murine model of myocardial infarction [19]. This evidence concerns the gene CD274 and heart disorder.